Perrigo Company plc Stock TEL AVIV STOCK EXCHANGE
Stocks
PRGO
IE00BGH1M568
Pharmaceuticals
| Market Cap | 1.4B 4.29B 1.22B 1.13B 1.04B 1.96B 134B 1.99B 13.34B 5.24B 66.48B 5.25B 5.14B 223B | P/E 2026 * |
-5.78x | P/E 2027 * | -22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.34B 13.3B 3.77B 3.51B 3.22B 6.09B 414B 6.18B 41.37B 16.24B 206B 16.29B 15.93B 691B | EV / Sales 2026 * |
1.07x | EV / Sales 2027 * | 1.03x |
| Free-Float |
99.6% | Yield 2026 * |
11.4% | Yield 2027 * | 11.7% |
Last Transcript: Perrigo Company plc
| 1 day | +0.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Manzone
CEO | Chief Executive Officer | 63 | 2026-06-06 |
Eduardo Bezerra
DFI | Director of Finance/CFO | 51 | 2022-05-15 |
Matt Winterman
COO | Chief Operating Officer | - | 2025-06-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Donal O'Connor
BRD | Director/Board Member | 75 | 2014-10-31 |
Geoffrey Parker
BRD | Director/Board Member | 61 | 2016-11-06 |
Bradley Alford
BRD | Director/Board Member | 70 | 2017-02-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -2.55% | - | - | 1.4B | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +1.00% | -0.97% | +39.84% | +33.58% | 349B | |
| +0.02% | -1.63% | +33.66% | +41.95% | 297B | |
| -4.68% | -7.09% | +7.53% | +9.85% | 264B | |
| +0.50% | -5.73% | -1.66% | -42.65% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| Average | -0.41% | -1.35% | +28.51% | +50.40% | 397.08B | |
| Weighted average by Cap. | +0.10% | -2.17% | +36.83% | +73.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.06B 12.46B 3.53B 3.29B 3.02B 5.7B 388B 5.79B 38.75B 15.21B 193B 15.26B 14.92B 648B | 4.11B 12.59B 3.57B 3.32B 3.05B 5.76B 392B 5.85B 39.16B 15.37B 195B 15.42B 15.08B 654B |
| Net income | -246M -754M -214M -199M -183M -345M -23.49B -351M -2.35B -921M -11.69B -924M -904M -39.21B | -62.3M -191M -54.16M -50.41M -46.28M -87.4M -5.95B -88.75M -594M -233M -2.96B -234M -229M -9.93B |
| Net Debt | 2.94B 9.01B 2.55B 2.38B 2.18B 4.12B 281B 4.19B 28.03B 11B 140B 11.04B 10.8B 468B | 2.83B 8.67B 2.46B 2.29B 2.1B 3.97B 270B 4.03B 26.97B 10.59B 134B 10.62B 10.39B 451B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
